Literature DB >> 10903150

Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase.

M Chiariello1, E Gomez, J S Gutkind.   

Abstract

Mitogen-activated protein (MAP) kinases, p42(MAPK) and p44(MAPK), are central components of growth-promoting signalling pathways. However, how stimulation of MAP kinases culminates in cell-cycle progression is still poorly understood. Here we show that mitogenic stimulation of NIH 3T3 cells causes a sustained activation of MAP kinases, which lasts until cells begin progressing through the G(1)/S boundary. Furthermore, we observed that disruption of the MAP-kinase pathway with a selective MEK (MAP kinase/extracellular-signal-regulated protein kinase kinase) inhibitor, PD98059, prevents the activation of cyclin-dependent kinase (Cdk) 2 and DNA synthesis, even when added during late G(1) phase, once the known mechanisms by which MAP kinase controls G(1) progression, accumulation of G(1) cyclins and degradation of Cdk inhibitors have already taken place. Moreover, we provide evidence indicating that MAP kinases control Cdk2 Thr-160 activating phosphorylation and function, possibly by regulating the activity of a Cdk-activating kinase, thus promoting the re-initiation of DNA synthesis. These findings suggest the existence of a novel mechanism whereby signal-transducing pathways converging on MAP kinases can affect the cell-cycle machinery and, ultimately, participate in cell-growth control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903150      PMCID: PMC1221216          DOI: 10.1042/bj3490869

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

Review 1.  D-type cyclins.

Authors:  C J Sherr
Journal:  Trends Biochem Sci       Date:  1995-05       Impact factor: 13.807

2.  Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.

Authors:  G Pagès; P Lenormand; G L'Allemain; J C Chambard; S Meloche; J Pouysségur
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 3.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

4.  Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.

Authors:  A Brunet; G Pagès; J Pouysségur
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

Review 5.  Principles of CDK regulation.

Authors:  D O Morgan
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

6.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

Review 7.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

8.  Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

Authors:  K Polyak; M H Lee; H Erdjument-Bromage; A Koff; J M Roberts; P Tempst; J Massagué
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

9.  A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.

Authors:  R P Fisher; D O Morgan
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

10.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  13 in total

1.  Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.

Authors:  Drew Burdon; Rajnikant Patel; R A John Challiss; Jonathan L Blank
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 2.  Cytokine signaling to the cell cycle.

Authors:  Frederick W Quelle
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Changes in Pirh2 and p27kip1 expression following traumatic brain injury in adult rats.

Authors:  Xiujie Wu; Wei Shi; Wei Zhao; Bai Shao; Qin Yuan; Chunmiao Li; Shuangwei Zhang; Binbin Sun; Qiyun Wu; Jian Chen
Journal:  J Mol Neurosci       Date:  2011-07-05       Impact factor: 3.444

4.  Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".

Authors:  Laurence Bockstaele; Hugues Kooken; Frederick Libert; Sabine Paternot; Jacques E Dumont; Yvan de Launoit; Pierre P Roger; Katia Coulonval
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.

Authors:  Rafael Kramann; Susanne V Fleig; Rebekka K Schneider; Steven L Fabian; Derek P DiRocco; Omar Maarouf; Janewit Wongboonsin; Yoichiro Ikeda; Dirk Heckl; Steven L Chang; Helmut G Rennke; Sushrut S Waikar; Benjamin D Humphreys
Journal:  J Clin Invest       Date:  2015-07-20       Impact factor: 14.808

6.  MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells.

Authors:  Yue Wang; Brent R Weil; Jeremy L Herrmann; Aaron M Abarbanell; Jiangning Tan; Troy A Markel; Megan L Kelly; Daniel R Meldrum
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-19       Impact factor: 4.249

7.  A mouse model of uterine leiomyosarcoma.

Authors:  Katerina Politi; Matthias Szabolcs; Peter Fisher; Ana Kljuic; Thomas Ludwig; Argiris Efstratiadis
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

8.  Activation of Toll‐like receptor 9 inhibits lipopolysaccharide‐induced receptor activator of nuclear factor kappa‐ B ligand expression in rat B lymphocytes.

Authors:  Xiaoqian Yu; Jiang Lin; Qing Yu; Toshihisa Kawai; Martin A Taubman; Xiaozhe Han
Journal:  Microbiol Immunol       Date:  2014-01       Impact factor: 1.955

9.  Regulation of CDK4.

Authors:  Laurence Bockstaele; Katia Coulonval; Hugues Kooken; Sabine Paternot; Pierre P Roger
Journal:  Cell Div       Date:  2006-11-08       Impact factor: 5.130

10.  Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation.

Authors:  Qi Liu; Xing Liu; Jinlan Gao; Xiuyan Shi; Xihua Hu; Shusen Wang; Yang Luo
Journal:  Int J Biol Sci       Date:  2013-06-09       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.